Related by context. All words. (Click for frequent words.) 66 phase IIa clinical 66 Phase 2b study 65 Phase 2b trial 65 LHRH antagonist 65 Phase IIb clinical 65 Phase 2a trial 65 HuMax CD4 64 lubiprostone 64 Cetrorelix 64 EOquin 64 Phase 2b clinical 64 ozarelix 64 alvespimycin 64 Phenoptin 64 phase IIb clinical 64 ofatumumab 64 elagolix 63 Bicifadine 63 elotuzumab 63 Phase III 63 PREOS 63 Gabapentin GR 63 tezampanel 63 methylnaltrexone 63 Zerenex 63 ITAX 63 alvimopan 63 goserelin 63 registrational 62 phase IIb 62 phase IIb trial 62 Dacogen injection 62 pivotal Phase III 62 placebo controlled clinical 62 Phase IIb trial 62 confirmatory Phase III 62 Phase III clinical 62 Phase IIIb clinical 61 Bezielle 61 Phase IIa trial 61 BRIM2 61 Androxal TM 61 sunitinib malate 61 YONDELIS 61 Amrubicin 61 palonosetron 61 teduglutide 61 Troxatyl 61 Phase III randomized controlled 61 CIMZIA TM 61 oral ridaforolimus 61 interferon beta 1a 61 dose escalation Phase 61 Adlea 61 Phase Ib 61 fostamatinib 61 pitavastatin 61 SNT MC# 61 Phase IIB 61 bicifadine 61 AGGRASTAT ® 61 Increlex ® 61 luteinizing hormone releasing 61 FOLOTYN 61 ularitide 61 phase IIa 61 randomized Phase IIb 61 Phase Ib clinical 61 blinatumomab 60 Nuvion 60 Phase Ib study 60 lintuzumab 60 Phase IIb 60 ocrelizumab 60 tanespimycin 60 EOquin TM 60 relapsed refractory multiple myeloma 60 Vaprisol 60 KRN# 60 Zenvia ™ 60 dirucotide 60 CAELYX 60 desvenlafaxine 60 regorafenib 60 dextromethorphan quinidine 60 Urocidin 60 CR# vcMMAE 60 Menerba 60 Proxinium TM 60 MoxDuo IR 60 double blinded placebo 60 Phase 2b 60 SUCCEED trial 60 atacicept 60 interferon beta 1b 60 diabetic neuropathic pain 60 Herceptin trastuzumab 60 daclizumab 60 Ophena TM 60 RSD# 60 Phase Ib II 60 Phase 2a clinical 60 Phase #b/#a 60 Fibrillex TM 60 BCX# 60 Firazyr 60 oral deforolimus 60 alfimeprase 60 PREOS R 60 Phase IIa clinical 60 omacetaxine mepesuccinate 60 Asentar 60 tesmilifene 60 Ixempra 60 AQ4N 60 metastatic hormone refractory 60 Plicera 60 Elagolix 60 Laquinimod 60 PEG PAL 60 terlipressin 60 PRT# 60 bendamustine 60 Raptiva ® 60 nalbuphine ER 60 otelixizumab 60 TASQ 60 ONTAK 60 Betaferon ® 60 danoprevir 60 refractory AML 60 Neurodex 59 INCB# [001] 59 vilazodone 59 Lu AA# 59 EndoTAG TM -1 59 multicentre randomized 59 GALNS 59 placebo controlled randomized 59 glufosfamide 59 Phase 2a 59 ELACYT 59 Corlux 59 Phase 1b clinical 59 Insegia 59 Capesaris 59 Phase 2b clinical trials 59 teriflunomide 59 placebo controlled Phase 59 PF # [001] 59 ASA# 59 RhuDex ® 59 voclosporin 59 Rebif ® 59 Santhera 59 phase Ib 59 INC# 59 Loramyc R 59 Sosei 59 Archexin 59 ofatumumab HuMax CD# 59 PROMACTA 59 ixabepilone 59 TEMODAL 59 BAY #-# 59 PDE4 inhibitor 59 Loramyc 59 apaziquone 59 symptomatic BPH 59 Zelrix 59 zanolimumab 59 Panzem R NCD 59 forodesine 59 OZURDEX ® 59 Phase IIIb 59 ganetespib 59 custirsen 59 PRX # 59 TBC# 59 NGX# 59 Ereska 59 CA4P 59 albinterferon alfa 2b 59 ADVANCE PD 59 LCP AtorFen 59 Plenaxis TM 59 IIa trial 59 LIALDA 59 refractory metastatic colorectal cancer 59 eltrombopag 59 Indaflex TM 59 nab paclitaxel 59 DU #b 59 LibiGel ® 59 acyclovir Lauriad R 59 dose escalation trial 59 fipamezole 59 Q#IR 59 Azedra 59 Phase IIb trials 59 iniparib 59 canakinumab 59 CIMZIA ™ 59 velaglucerase alfa 59 Dextofisopam 59 tocilizumab 59 MIRCERA 59 Traficet EN 59 visilizumab 59 Cloretazine ® 58 alogliptin 58 Phase IIa trials 58 pradefovir 58 Azilect ® 58 anticancer compound 58 Phase III trials 58 Advagraf 58 Allovectin 7 58 GATTEX 58 Targretin capsules 58 orBec 58 Amigal 58 Rezular 58 diarrhea predominant irritable 58 Æterna Zentaris 58 OLEPTRO TM 58 BEMA Buprenorphine 58 eprotirome 58 GnRH antagonist 58 HuLuc# 58 L BLP# 58 ELND# 58 Silodosin 58 JAK inhibitor 58 odanacatib 58 multicenter randomized placebo controlled 58 RSD# oral 58 degarelix 58 rALLy clinical trial 58 PEG INTRON 58 sitaxsentan 58 HuMax CD# 58 Lodotra 58 hypoparathyroidism 58 placebo controlled Phase III 58 E1 INT TM 58 registrational trial 58 Betaferon R 58 Ventavis 58 Cloretazine R VNP#M 58 Alzhemed TM 58 MDV# 58 castrate resistant prostate cancer 58 Clolar ® 58 PRX# 58 ospemifene 58 HGS ETR1 58 Mipomersen 58 XL# [003] 58 ThermoDox ® 58 Anturol TM 58 febuxostat 58 HCD# [002] 58 VPRIV 58 subcutaneous formulation 58 Viramidine 58 cetrorelix pamoate 58 TELINTRA 58 valopicitabine 58 relapsed ovarian cancer 58 SinuNase 58 OncoVEX GM CSF 58 oral rivaroxaban 58 DDP# 58 denufosol 58 decitabine 58 AP# [003] 58 cangrelor 58 NEBIDO 58 recurrent ovarian cancer 58 Aryplase 58 eculizumab 58 belinostat 58 tramiprosate ALZHEMED TM 58 TRISENOX 58 HspE7 58 calcineurin inhibitor 58 Vectibix panitumumab 58 M6G 58 PRECiSE 58 lumiliximab 58 pralatrexate 58 Phase 1b trial 58 NUVIGIL 58 ACTEMRA TM 58 abiraterone acetate 58 vidofludimus 58 OMAPRO 58 Tamibarotene 58 Phase IIa 58 ambrisentan 58 Tocosol Paclitaxel 58 controlled multicenter 58 XIAFLEX ® 58 reslizumab 58 PXD# 58 Increlex R 58 Civacir 58 Nexavar sorafenib 58 sorafenib Nexavar 58 metastatic castrate resistant 58 TOCOSOL Paclitaxel 58 pegloticase 58 ATACAND 58 opioid induced bowel dysfunction 57 Avastin bevacizumab 57 relapsed multiple myeloma 57 Androxal 57 Phase #/#a 57 Phase III Pivotal 57 AZILECT R 57 Phase IIb clinical trials 57 BioSTAR R 57 HuMax EGFr 57 pertuzumab 57 multicenter Phase 57 AeroLEF TM 57 vandetanib 57 receptor tyrosine kinase inhibitor 57 eniluracil 57 PLK1 SNALP 57 oral prodrug 57 VAPRISOL 57 Mepact 57 Pennsaid R 57 subcutaneously administered 57 Dyloject TM 57 metastatic HRPC 57 Phase Ib clinical trials 57 dose escalation 57 Serada 57 Chemophase 57 Urocidin TM 57 cinacalcet HCl 57 AEGR 57 OvaRex ® MAb 57 deforolimus 57 TORISEL 57 rilonacept 57 Diamyd ® 57 Prosaptide 57 tenofovir emtricitabine 57 Nebido 57 6R BH4 57 efficacy endpoint 57 Taxotere R 57 metaglidasen 57 biologic therapy 57 GSK# [001] 57 TELCYTA 57 Alpharadin 57 LEUKINE 57 Pimavanserin 57 TACI Ig 57 Neuradiab 57 assessing T DM1 57 bazedoxifene 57 Velcade bortezomib 57 Stimuvax R 57 LIVALO 57 Phase 1b dose escalation 57 laquinimod 57 lomitapide 57 CEQ# 57 incyclinide 57 Desmoteplase 57 enzastaurin 57 MIST II 57 Lialda 57 Raptiva R 57 C1 INH 57 RITUXAN 57 Pivotal Phase 57 BRIM3 57 adecatumumab 57 AGGRASTAT R 57 clofarabine 57 mipomersen 57 pegylated liposomal doxorubicin 57 Catena ® 57 Allovectin 7 ® 57 EFAPROXYN 57 Cellegesic 57 picoplatin 57 Androxal ® 57 Icatibant 57 Theratope 57 Nasulin 57 Diamyd R 57 Elocalcitol 57 desvenlafaxine succinate 57 Stimuvax 57 OPAXIO 57 romidepsin 57 Sym# 57 perifosine 57 Frova ® 57 PHX# 57 Marqibo 57 Degarelix 57 Saxagliptin 57 Hypoactive Sexual Desire Disorder 57 PhosLo 57 Pivotal Phase III 57 ATL# [001] 57 MEK inhibitor 57 immunomodulatory therapy 57 TMC# C# 57 oral calcitonin 57 tezampanel NGX# 57 Aflibercept 57 lintuzumab SGN 57 MYDICAR ® 57 ONGLYZA ™ 57 Dabigatran etexilate 57 CoFactor 57 Myocet 57 cabozantinib 57 LymphoStat B 57 Genz # 57 celgosivir 57 ThermoDox R 57 Phase III Clinical Trials 57 GetGoal Phase III 57 talactoferrin 57 Ceflatonin R 57 capecitabine Xeloda 57 ruxolitinib 57 Fx #A 57 hypogonadal men 57 Benlysta belimumab 57 ZOLINZA 57 ORENCIA ® 57 relapsing multiple sclerosis 57 peginterferon alfa 2b 57 phase Ib clinical 57 DP b# 57 Zensana TM 57 Mylotarg 57 Golimumab 57 Ozarelix 57 velafermin 57 ATryn R 57 ARIKACE ™ 57 acute ischemic stroke 57 JANUVIA 57 NPSP# 57 refractory CLL 57 refractory Hodgkin lymphoma 57 GLPG# 57 Pegasys peginterferon alfa 2a 57 ALN PCS 57 Dalbavancin 57 mixed dyslipidemia 57 PRISTIQ 57 evaluating tivozanib 57 Amplimexon 57 trospium 56 multicenter placebo controlled 56 DEXILANT 56 dacetuzumab 56 axitinib 56 Phase Ia 56 Phase 1b 56 HGS# 56 tamibarotene 56 APEX PD 56 oral methylnaltrexone 56 ancrod 56 microplasmin 56 silodosin 56 Zoraxel 56 BAL# [002] 56 Triolex 56 octreotide implant 56 painful diabetic neuropathy 56 Emselex 56 avanafil 56 vernakalant 56 Vernakalant 56 low dose cytarabine 56 pomalidomide 56 NP2 Enkephalin 56 Alfimeprase 56 Loramyc ® 56 Ophena 56 LUMINATE 56 pseudobulbar affect PBA 56 Alocrest 56 GATTEX ® 56 Nexavar ® 56 clinical trial 56 Northera 56 brivaracetam 56 ibandronate 56 docetaxel Taxotere R 56 linaclotide 56 IV bolus 56 Rhucin 56 Gattex 56 SUPPRELIN R LA 56 Zalbin 56 metastatic CRC 56 Luteinizing Hormone Releasing Hormone 56 TG# [001] 56 Amitiza 56 catheter occlusion 56 AEZS 56 TH# [003] 56 volociximab 56 Dapagliflozin 56 HZT 56 Preotact 56 PEGINTRON TM 56 overactive bladder OAB 56 Mycamine 56 TroVax ® 56 baminercept 56 Proellex TM 56 Evoltra 56 sargramostim 56 selective androgen receptor modulator 56 Somatuline R Autogel R 56 Augment Injectable 56 PD LID 56 Faslodex 56 dabigatran etexilate 56 adalimumab 56 AGILECT R 56 refractory APL 56 opioid induced constipation OIC 56 recurrent GBM 56 Topical Interferon Alpha 2b 56 IoGen 56 octreotide 56 dose escalation clinical 56 BrachySil TM 56 Pirfenidone 56 Tavocept 56 GW# [003] 56 TYKERB 56 Phase III placebo controlled 56 Dacogen decitabine 56 Fludara 56 Xyrem ® 56 COMFORT II 56 ponatinib 56 ATL# [002] 56 oral formulation 56 obatoclax 56 Phase III clinical trials 56 DAPT 56 satraplatin 56 ARCOXIA 56 viral kinetic 56 MAGE A3 ASCI 56 peginesatide 56 lixisenatide 56 Omnitarg 56 HRPC 56 Tyrima 56 TRANSDUR Sufentanil 56 R#/MEM # 56 Phase III Clinical Trial 56 GVAX immunotherapy 56 Ceflatonin 56 Stedivaze 56 Plenaxis R 56 telbivudine 56 Synavive 56 relapsing remitting multiple sclerosis 56 Copegus ribavirin 56 AEG# 56 aleglitazar 56 Torisel 56 FOLOTYN ® 56 refractory multiple myeloma 56 BST CarGel R 56 PF # [002] 56 cannabinor 56 REOLYSIN ® 56 Targretin 56 Oxypurinol 56 Phase 1a clinical 56 aflibercept 56 tesetaxel 56 rindopepimut 56 TLK# 56 synthetic retinoid 56 elacytarabine 56 ocular hypertension 56 ILUVIEN ® 56 RG# [001] 56 fenofibric acid 56 lacosamide 56 blinded randomized 56 ACZ# 56 SCH # 56 Zavesca r 56 multicenter Phase III 56 pregabalin 56 neurogenic orthostatic hypotension 56 Zenvia 56 paliperidone ER 56 Omigard 56 ARCALYST ® 56 BR.# 56 phase IIb study 56 KNS # 56 oral fludarabine 56 ThGRF 56 rasagiline tablets 56 INTERCEPT platelets 56 randomized blinded 56 active comparator 56 metastatic castration resistant 56 omecamtiv mecarbil 56 investigational drug 56 TMC# [002] 56 Gelnique 56 multiple ascending dose 56 SUTENT 56 Erbitux cetuximab 56 ZACTIMA 56 MAXY G# 56 dirucotide MBP# 56 GED aPC 56 Quinamed 56 Randomized Phase 56 Phase III psoriasis 56 ISIS # 56 Vilazodone 56 ISTODAX 56 pivotal Phase 56 CD3 monoclonal antibody 56 THALOMID 56 ALGRX 56 Certican 56 ezogabine 56 DPP4 inhibitor 56 bevacizumab Avastin ® 56 Aurexis 56 Xeloda capecitabine 56 LUX Lung 56 dalbavancin 56 Ambrisentan 56 R#/MEM 56 Phase III HEAT 56 figitumumab 56 Factor Xa inhibitor 56 GFT# 56 Velac 56 overactive bladder syndrome 56 epratuzumab 56 Relistor 56 concurrent chemoradiation 56 Syncria 56 T DM1 56 Matrix Phase 2b 56 Onalta 56 UVIDEM 56 ALN TTR# 56 PRIALT 56 Mirapexin 56 frovatriptan 56 Iluvien ® 56 clevudine 56 Actemra tocilizumab 56 Itopride 56 maximally tolerated dose 55 Onrigin TM 55 multicenter Phase II 55 IMC #B 55 phase IIb III 55 MAA submission 55 CLARITY study 55 ZYBRESTAT fosbretabulin 55 phase IIIb 55 ALISTA 55 REVLIMID lenalidomide 55 CCX# 55 rFVIIIFc 55 SCHWARZ PHARMA 55 GATTEX TM 55 Hycamtin ® 55 octreotide acetate 55 vasomotor symptoms 55 mapatumumab 55 prGCD 55 dose cohort 55 optimal dosing 55 Neulasta ® 55 FASLODEX 55 ridaforolimus 55 almorexant 55 granulated mesalamine 55 monotherapy 55 superficial bladder cancer 55 Solazed 55 TREDAPTIVE 55 Jevtana 55 ZYBRESTAT 55 serotonin norepinephrine reuptake inhibitor 55 Fortigel 55 Teysuno 55 EXPAREL ™ 55 evaluating REVLIMID 55 XmAb# 55 LibiGel 55 confirmatory Phase 3 55 PRE SURGE 55 cilengitide 55 PROVENGE sipuleucel T 55 Locteron ® 55 lesinurad 55 EDEMA3 55 dexanabinol 55 ANYARA 55 Panzem R 55 BEXXAR 55 proteasome inhibitor 55 oral anticoagulant 55 brentuximab vedotin 55 rNAPc2 55 epothilone 55 Luveniq 55 Solasia 55 MGCD# [001] 55 phase 2a 55 INCB# [002] 55 investigational oral 55 pegfilgrastim 55 budesonide foam 55 SEROQUEL 55 Aclasta 55 secondary hypogonadism 55 Abilify aripiprazole 55 zalutumumab 55 post menopausal osteoporosis 55 Clonicel 55 oral salmon calcitonin 55 Cimzia ® certolizumab pegol 55 REMINYL ® 55 antiarrhythmic drug 55 midstage trials 55 GnRH agonist 55 Cx# [002] 55 REVLIMID ® 55 Neoadjuvant 55 certolizumab 55 Viprinex TM 55 EXPAREL TM 55 investigational compound 55 AZX# 55 Somatuline Depot 55 apremilast 55 beta 1a 55 dose cohorts 55 Cladribine Tablets 55 HER2 positive metastatic breast 55 Phase #b/#a clinical 55 IMGN# 55 Phase #b/#a trial 55 Frova 55 LODOTRA 55 dose dose escalation 55 Onsolis 55 Genasense 55 postmenopausal osteoporosis 55 PREGNANT Study 55 Ocrelizumab 55 photoprotective drug 55 Ruconest 55 PTH1 55 refractory prostate cancer 55 WILEX 55 alemtuzumab Campath 55 metastatic renal cell carcinoma 55 advanced metastatic prostate 55 infusional 5-FU/LV 55 PEG Interferon lambda 55 Cimzia TM 55 Vasovist 55 FTY# 55 Allovectin 7 R 55 MGd 55 rufinamide 55 MEND CABG II 55 MERLIN TIMI 55 Lupuzor 55 ACTEMRA 55 HCV SPRINT 55 NVA# 55 Telaprevir 55 efalizumab 55 azacitidine 55 acyclovir Lauriad ® 55 Taxotere ® 55 Diabetic Macular Edema 55 platinum refractory 55 Arcalyst 55 CCX# B 55 AIR CF3 55 AVE# 55 radiation sensitizer 55 multicenter clinical 55 Sycrest 55 liposomal formulation 55 neratinib 55 Clevudine 55 MEND CABG 55 oxycodone CR 55 taspoglutide 55 Onco TCS 55 Zirgan 55 tafamidis 55 RGB # 55 midstage clinical 55 Virulizin R 55 CD# antibody [001] 55 EVIZON 55 antiplatelet agent 55 Shigamabs ® 55 rFVIIa 55 MBP# [001] 55 severe hypercholesterolemia 55 BEMA TM Fentanyl 55 histamine dihydrochloride 55 Lung Rx 55 Betaferon 55 Tanespimycin 55 BENICAR HCT 55 forodesine hydrochloride 55 Pegasys plus Copegus 55 Phase 1a 55 Glypromate 55 ISENTRESS 55 primary hypercholesterolemia 55 Dr. Fahar Merchant 55 evaluating Xcytrin 55 cathepsin K inhibitor 55 ACAPODENE 55 Aromasin 55 Clavis Pharma 55 pemetrexed 55 asenapine 55 BioNumerik 55 PROSTVAC ® 55 Asenapine 55 SAR# [004] 55 RezularTM 55 STRIDE PD 55 Carfilzomib 55 ILLUMINATE 55 LibiGel Phase III 55 randomized multicenter 55 ATIR TM 55 cetuximab Erbitux 55 initiate Phase 1b 55 SYMMETRY trial 55 PEG SN# 55 Femara letrozole 55 Clolar 55 double blinded randomized 55 Phase III TRIST 55 randomized clinical 55 CANCIDAS 55 carcinoid syndrome 55 nonrandomized 55 arzoxifene 55 LymphoStat B TM 55 trastuzumab Herceptin 55 veltuzumab 55 Serdolect ® 55 Besivance 55 MONOVISC 55 idursulfase 55 MACUGEN 55 MoxDuo TM IR 55 Relivar 55 Initiate Phase 55 BRAF inhibitor 55 castration resistant prostate cancer 55 ORMD 55 Veronate 55 CB2 selective receptor agonist 55 Tarceva TM 55 Edoxaban 55 Safinamide 55 Octreolin 55 CIMZIA TM certolizumab pegol 55 dose escalation study 55 docetaxel 55 NLX P# 55 clinical pharmacology studies 55 TREANDA 55 relapsed MM 55 mycophenolate mofetil 55 dextofisopam 55 Voraxaze 55 IRX 2 55 inhaled formulation 55 dose escalation phase 55 SEPET TM 55 Cimzia certolizumab pegol 55 Zavesca R 55 GVAX 55 trastuzumab DM1 55 vinorelbine 55 IMA# 55 QNEXA 55 BLA filing 55 Irinotecan 55 Testosterone MDTS ® 55 KAPIDEX 55 darusentan 55 pimavanserin 55 mertansine 55 Prestara 55 Zybrestat 55 AZOR 55 sorafenib tablets 55 delivers fluocinolone acetonide FA 55 Aplidin 55 lurasidone 55 icatibant 55 LEVADEX ™ 55 Ketotransdel 55 tremelimumab 54 investigational therapies 54 candesartan cilexetil 54 docetaxel chemotherapy 54 Phase III confirmatory 54 Ostarine 54 Spiegelmer ® 54 rALLy trial 54 Alvesco R 54 FlutiformTM 54 prospective randomized placebo 54 Telcyta 54 oxymorphone ER 54 lorvotuzumab mertansine 54 APTIVUS 54 SUTENT ® 54 Pemetrexed 54 Medidur TM FA 54 ulimorelin 54 tasocitinib 54 bardoxolone 54 clinical trials 54 Bronchitol 54 Chrysalin 54 Tarceva erlotinib 54 refractory gout 54 mometasone furoate 54 Darusentan 54 atrasentan 54 ALN RSV# 54 torezolid phosphate 54 fosbretabulin 54 LHRH agonists 54 Junovan 54 subcutaneous SC 54 cinacalcet 54 PSD# 54 Nanobody 54 ELADUR 54 Aurora kinase inhibitor 54 dexpramipexole 54 bevacizumab Avastin 54 LCP Tacro 54 Dacogen 54 CALGB # [001] 54 Zoledronic acid 54 Natalizumab 54 IV APAP 54 oral treprostinil 54 ProSavin 54 MabThera rituximab 54 NXL# 54 CDP# 54 miglustat 54 adipiplon 54 pegylated interferons 54 Phase IIa clinical trials 54 inhaled treprostinil 54 Zingo TM 54 refractory PTCL 54 inhibitor RG#